title: Can we optimize long-term outcomes in acute respiratory distress syndrome by targeting normoxemia?
abstract: Since its original description in 1967, acute respiratory distress syndrome (ARDS) has been recognized as a devastating condition associated with significant morbidity and mortality. Advances in critical care medicine and ARDS management have led to a substantial increase in the number of ARDS survivors. Long-term cognitive impairment after critical illness is a significant public health concern. ARDS survivors frequently experience long-term cognitive impairment, as well as physical impairment, psychiatric morbidity, and reduced health-related quality of life. At present, no intensive care unit-based intervention has been proven to reduce the risk of long-term cognitive impairment after ARDS. To address the urgent need to identify strategies to preserve long-term health, investigators have advocated the measurement of short- and long-term outcomes in clinical trials. Maintaining adequate oxygen delivery to preserve organ function is of vital importance in ARDS management. The optimal target range for arterial oxygenation in ARDS remains unknown, due in part to the challenge to maintain adequate tissue oxygenation and to minimize harm, such as oxygen toxicity. An approach targeted to subnormal oxygenation values (partial pressure of arterial oxygen, 55-80 mm Hg) has emerged as a means to accomplish these aims. In this perspective, we critically evaluate this strategy from short- and long-term perspectives, with a focus on the potential long-term cognitive effects of the strategy. We conclude with a proposal to consider resetting the target range for arterial oxygenation higher (85-110 mm Hg) as a potential strategy to improve the long-term outcomes of ARDS survivors.
authors.affiliation: 1 Pulmonary, Allergy, and Critical Care Division, Department of Medicine.
authors.forename: Mark E
authors.initials: ME
authors.lastname: Mikkelsen
authors.forename: Brian
authors.initials: B
authors.lastname: Anderson
authors.forename: Jason D
authors.initials: JD
authors.lastname: Christie
authors.forename: Ramona O
authors.initials: RO
authors.lastname: Hopkins
authors.forename: Paul N
authors.initials: PN
authors.lastname: Lanken
mesh_terms: D003072:Cognition Disorders / Q000517:prevention & control*; D003422:Critical Care / Q000379:methods*; D006801:Humans; D000860:Hypoxia / Q000628:therapy*; D010092:Oximetry; D010347:Patient Care Planning; D011788:Quality of Life; D012128:Respiratory Distress Syndrome / Q000628:therapy*